HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alfredo Falcone Selected Research

Sorafenib (BAY 43-9006)

12/2020Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study.
1/2020Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study.
8/2013Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.
2/2013Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alfredo Falcone Research Topics

Disease

143Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2002
70Neoplasms (Cancer)
03/2022 - 12/2002
28Neoplasm Metastasis (Metastasis)
01/2021 - 01/2006
17Disease Progression
10/2021 - 03/2008
14Pancreatic Neoplasms (Pancreatic Cancer)
06/2020 - 01/2008
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 05/2006
11Adenocarcinoma
03/2022 - 06/2010
9Stomach Neoplasms (Stomach Cancer)
03/2021 - 02/2004
9Prostatic Neoplasms (Prostate Cancer)
01/2018 - 08/2009
8Breast Neoplasms (Breast Cancer)
03/2022 - 08/2009
8Neutropenia
06/2021 - 03/2008
6Rectal Neoplasms (Rectal Cancer)
07/2020 - 05/2014
6Hypertension (High Blood Pressure)
12/2019 - 08/2009
5Diarrhea
08/2020 - 03/2004
5Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2018
5Fatigue
12/2019 - 03/2007
4Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2020 - 01/2011
4Melanoma (Melanoma, Malignant)
02/2020 - 01/2017
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
02/2021 - 10/2006
3Microsatellite Instability
01/2021 - 01/2018
3Hepatocellular Carcinoma (Hepatoma)
12/2020 - 02/2014
3Febrile Neutropenia
08/2020 - 09/2010
2Carcinogenesis
03/2022 - 03/2012
2Anemia
06/2021 - 01/2009
2Carcinoma (Carcinomatosis)
02/2020 - 01/2019
2Drug-Related Side Effects and Adverse Reactions
12/2019 - 10/2006
2Inflammation (Inflammations)
01/2019 - 10/2015
2Vomiting
01/2017 - 01/2009

Drug/Important Bio-Agent (IBA)

46Bevacizumab (Avastin)FDA Link
03/2022 - 05/2007
42Irinotecan (Camptosar)FDA LinkGeneric
11/2020 - 04/2002
35Fluorouracil (Carac)FDA LinkGeneric
02/2021 - 10/2002
30Cetuximab (Erbitux)FDA Link
01/2022 - 09/2007
28Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 10/2002
26ErbB Receptors (EGF Receptor)IBA
01/2022 - 09/2007
25Biomarkers (Surrogate Marker)IBA
02/2021 - 03/2010
21Leucovorin (Folinic Acid)FDA Link
07/2020 - 10/2002
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 05/2007
16Monoclonal AntibodiesIBA
01/2022 - 01/2008
14GemcitabineFDA Link
01/2020 - 01/2008
13regorafenibIBA
12/2021 - 01/2013
10trifluridine tipiracil drug combinationIBA
06/2021 - 01/2015
10Pharmaceutical PreparationsIBA
06/2021 - 12/2002
9Panitumumab (Vectibix)FDA Link
01/2022 - 12/2008
9DNA (Deoxyribonucleic Acid)IBA
01/2019 - 08/2009
8Proteins (Proteins, Gene)FDA Link
03/2021 - 04/2007
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2021 - 08/2009
7Immune Checkpoint InhibitorsIBA
09/2021 - 01/2018
7folfirinoxIBA
01/2020 - 01/2016
7Capecitabine (Xeloda)FDA Link
01/2020 - 09/2006
6AntibodiesIBA
09/2021 - 07/2015
6Cisplatin (Platino)FDA LinkGeneric
08/2010 - 02/2004
5Paclitaxel (Taxol)FDA LinkGeneric
03/2022 - 08/2009
5Tyrosine Kinase InhibitorsIBA
10/2020 - 08/2008
5MicroRNAs (MicroRNA)IBA
06/2020 - 01/2012
5Docetaxel (Taxotere)FDA Link
12/2014 - 05/2006
4Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2022 - 12/2014
4PlatinumIBA
01/2022 - 12/2009
4Formaldehyde (Formol)FDA Link
03/2021 - 12/2008
4Messenger RNA (mRNA)IBA
03/2021 - 04/2013
4ParaffinIBA
03/2021 - 03/2010
4Sorafenib (BAY 43-9006)FDA Link
12/2020 - 02/2013
4130-nm albumin-bound paclitaxelIBA
01/2020 - 01/2016
4Biological ProductsIBA
01/2020 - 11/2009
4thiamine triphosphorate (TTP)IBA
06/2013 - 09/2006
3Calcibiotic Root Canal SealerIBA
01/2022 - 07/2015
3Celecoxib (Celebrex)FDA Link
02/2021 - 08/2009
3Epidermal Growth Factor (EGF)IBA
01/2021 - 09/2019
3Hormones (Hormone)IBA
01/2020 - 08/2009
3Circulating Tumor DNAIBA
12/2019 - 07/2015
3Antineoplastic Agents (Antineoplastics)IBA
01/2018 - 09/2007
3RNA (Ribonucleic Acid)IBA
01/2018 - 01/2012
3Vinorelbine (Navelbine)FDA LinkGeneric
01/2017 - 05/2006
3Gefitinib (Iressa)FDA Link
02/2011 - 08/2008
2GoldIBA
03/2022 - 11/2021
2Thrombospondin 1IBA
03/2022 - 12/2014
2Interleukin-8 (Interleukin 8)IBA
03/2022 - 12/2014
2InterferonsIBA
01/2022 - 02/2013
2atezolizumabIBA
07/2020 - 01/2019
2LigandsIBA
02/2020 - 09/2014
2Trastuzumab (Herceptin)FDA Link
01/2020 - 02/2018
2NivolumabIBA
01/2020 - 01/2020
2IfosfamideFDA LinkGeneric
01/2020 - 05/2006
2Epirubicin (Ellence)FDA LinkGeneric
01/2020 - 02/2004
2EnzymesIBA
12/2019 - 04/2013
2Codon (Codons)IBA
12/2019 - 12/2008
2Angiogenesis InhibitorsIBA
01/2019 - 08/2013
2AlbuminsIBA
08/2018 - 01/2018
2Androgen Receptors (Androgen Receptor)IBA
01/2018 - 01/2017
2NucleosidesIBA
01/2018 - 01/2011
2liposomal doxorubicin (Doxil)FDA Link
02/2017 - 11/2009
2Insulin-Like PeptidesIBA
01/2017 - 10/2010
2MitogensIBA
01/2017 - 02/2009

Therapy/Procedure

64Drug Therapy (Chemotherapy)
01/2022 - 10/2002
53Therapeutics
01/2022 - 09/2007
8Adjuvant Chemotherapy
11/2021 - 12/2002
6Immunotherapy
04/2022 - 05/2009
5Castration
01/2017 - 05/2010
2Heterologous Transplantation (Xenotransplantation)
08/2021 - 06/2020
2Neoadjuvant Therapy
01/2020 - 01/2019
2Chemoradiotherapy
01/2019 - 12/2015